integral original 2de gel image processing algorithms (MathWorks Inc)
Structured Review

Integral Original 2de Gel Image Processing Algorithms, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 2633 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integral original 2de gel image processing algorithms/product/MathWorks Inc
Average 96 stars, based on 2633 article reviews
Images
1) Product Images from "Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis"
Article Title: Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis
Journal: Biomedicines
doi: 10.3390/biomedicines10081821
Figure Legend Snippet: Comparative analysis of 2DE proteome maps characteristic for normal and polyhydramnios pregnancies. The proteins were resolved by 2DE, pH range 3–11, and Excel Gel SDS, gradient 8–18%. 2DE images of proteins of amniotic fluid of normal pregnancy (AFN, G1; blue in G1 + G2 and amniotic fluid of polyhydramnios pregnancy (AFP, G2; orange in G1 + G2) were superposed and presented in G1 + G2. Arrows and numbers in the 2DE maps indicate the positions of proteins supplied to MALDI-TOF MS/MS and identified. Spot labels are the same as in . Molecular weight (Mw) markers are presented on the left. Representative images from one of three experiments showing similar results are shown.
Techniques Used: Tandem Mass Spectroscopy, Molecular Weight
Figure Legend Snippet: The summarized search results (by UniProt, Expasy) of proteins identified from 2DE gels representing protein maps of amniotic fluid of normal and polyhydramnios pregnancies fractionated in the pI 3–11 range. An increase in spot intensity yields a positive fold-change and a decrease accordingly a negative fold-change in AFN/AFP (marked as G1/G2). a ) AC—accession number; b ) Score—protein Score C.I. %; c ) Match—Matching (sequence coverage, %); d ) TP—Theoretical Peptides; e ) DP—Digest Peptides; f ) FC—Fold Change.
Techniques Used: Sequencing, Clinical Proteomics, Membrane
Figure Legend Snippet: The summarized search results (by UniProt, Expasy) of proteins identified from 2DE gels representing protein maps of amniotic fluid of polyhydramnios pregnancy fractionated in pI 3–11 and pI 4–7 range. a ) AC—accession number; b ) Score—protein Score C.I. %; c ) Match—Matching (sequence coverage, %); d ) TP—Theoretical Peptides; e ) DP—Digest Peptides; f ) FC—Fold Change.
Techniques Used: Sequencing, Membrane
Figure Legend Snippet: Comparative analysis of 2DE protein maps corresponding amniotic fluid of polyhydramnios pregnancy fractionated in different pI range. ( A ) proteins corresponding amniotic fluid of polyhydramnios pregnancy (AFP), fractionated in different pI range: pI 3–11 (G2, blue in G2 + G3) and pI 4–7 (G3, orange in G2 + G3) range and Excel Gel SDS, gradient 8–18%. Arrows and numbers in the 2DE maps indicate the positions of proteins supplied to MALDI-TOF MS/MS and identified. Spot labels for the proteins fractionated in the range pI 3–11 are the same as in . Spot labels for the proteins fractionated in the range pI 4–7 are the same as in . ( B ) Computational analysis of several protein groups is performed to evaluate their distribution in different pI value ranges. It shows that the same protein level with different pI changes because of modification level. In , the proteins’ spot distribution corresponding to the different modification level is presented (column— Share, %). Representative images from one of three experiments showing similar results are shown.
Techniques Used: Tandem Mass Spectroscopy, Modification
Figure Legend Snippet: Identified AFP proteins—those expressions are higher in comparison to proteome associated with normal pregnancy in 2DE gels with pI 3–11 ranges (right panel) and AFP proteins, the spots number of which (proportionate to modification) in AFP pI 4–7 differ in comparison to fractionated in pI 3–11 range (left panel).
Techniques Used: Comparison, Modification, Expressing, Clinical Proteomics, Membrane